ROYCE & ASSOCIATES LP - INTERSECT ENT INC ownership

INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 106 filers reported holding INTERSECT ENT INC in Q1 2017. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of INTERSECT ENT INC
ValueSharesWeighting
Q3 2019$680,000
-61.2%
40,000
-48.1%
0.01%
-62.5%
Q2 2019$1,753,000
-29.2%
77,0000.0%0.02%
-23.8%
Q1 2019$2,476,000
-12.1%
77,000
-23.0%
0.02%
-16.0%
Q4 2018$2,818,000
-2.0%
100,0000.0%0.02%
+25.0%
Q3 2018$2,875,000
+195.2%
100,000
+284.6%
0.02%
+185.7%
Q2 2018$974,000
-70.8%
26,000
-69.4%
0.01%
-69.6%
Q1 2018$3,340,000
+9.7%
85,000
-9.6%
0.02%
+15.0%
Q4 2017$3,046,000
+4.0%
94,0000.0%0.02%
+5.3%
Q3 2017$2,928,000
+11.5%
94,0000.0%0.02%
+11.8%
Q2 2017$2,627,000
+63.0%
94,0000.0%0.02%
+54.5%
Q1 2017$1,612,000
-52.6%
94,000
-66.5%
0.01%
-50.0%
Q4 2016$3,398,000
-53.4%
280,800
-39.1%
0.02%
-54.2%
Q3 2016$7,299,000
+5.8%
460,800
-13.7%
0.05%
+4.3%
Q2 2016$6,902,000
+3.7%
533,800
+52.3%
0.05%
+9.5%
Q1 2016$6,658,000
-29.6%
350,400
-16.7%
0.04%
-25.0%
Q4 2015$9,459,000
+11.2%
420,400
+15.7%
0.06%
+24.4%
Q3 2015$8,506,000
-30.4%
363,500
-14.8%
0.04%
-13.5%
Q2 2015$12,214,000
+34.5%
426,600
+21.3%
0.05%
+52.9%
Q1 2015$9,082,000
+50.6%
351,600
+8.2%
0.03%
+61.9%
Q4 2014$6,029,000
+19.7%
325,0000.0%0.02%
+23.5%
Q3 2014$5,038,000325,0000.02%
Other shareholders
INTERSECT ENT INC shareholders Q1 2017
NameSharesValueWeighting ↓
KOPP INVESTMENT ADVISORS LLC 186,561$5,364,0004.51%
First Light Asset Management, LLC 517,121$14,867,0002.40%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,147,950$61,754,0002.21%
HealthCor Management, L.P. 1,950,000$56,063,0001.86%
PURA VIDA INVESTMENTS, LLC 200,000$5,750,0001.21%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 112,000$2,469,0001.17%
Broadfin Capital, LLC 234,200$6,733,0000.99%
Lombard Odier Asset Management (USA) Corp 240,000$6,900,0000.51%
PURA VIDA INVESTMENTS, LLC 83,527$2,401,0000.50%
Rock Springs Capital Management LP 460,000$13,225,0000.48%
View complete list of INTERSECT ENT INC shareholders